Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-861
Closed -$210K 394
2021
Q2
$210K Sell
861
-30
-3% -$7.38K 0.02% 353
2021
Q1
$222K Sell
891
-6,260
-88% -$1.49M 0.02% 306
2020
Q4
$1.64M Buy
7,151
+216
+3% +$49.8K 0.16% 96
2020
Q3
$1.76M Buy
+6,935
New +$1.72M 0.18% 91
2018
Q1
Sell
-33,251
Closed -$5.78M 409
2017
Q4
$5.78M Buy
+33,251
New +$5.88M 0.67% 52

Other funds holding AMGN

6 Meridian's AMGN Position: Q3 2021 in Review

6 Meridian sold out of Amgen (AMGN) in Q3 2021, closing a stake of 861 shares — an estimated $210K sold.

6 Meridian first reported a position in AMGN in Q4 2017 and held it in 5 quarters. The position peaked at $5.78M in Q4 2017. 2,132 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • 6 Meridian reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • 6 Meridian sold 861 Amgen shares in Q3 2021, an estimated $210K.
  • 6 Meridian first reported a position in Amgen in Q4 2017 and held it in 5 quarters.
  • 6 Meridian's Amgen position peaked at $5.78M in Q4 2017.
  • 2,132 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.